Drug and Device News [0.03%]
药讯医疗器械简报
Approvals, new indications and formulations, and safety issues.
FTC Gives Generics Victory On "Pay for Delay": Reverse Payments Crimped, Patent Thickets Untouched [0.03%]
美国联邦贸易委员会叫好又叫座的药品专利“付钱延缓诉讼”协议被判违法但“专利厚篱笆”依然有效
Stephen Barlas
Stephen Barlas
How easy is it for generics to enter the market? It could be easier with legislation that opens up the field for generic competitors, but it is unlikely that such a bill will ever be introduced.
Matthew Grissinger
Matthew Grissinger
Indication-based prescribing has many potential benefits, including preventing errors by reducing medication choices and assisting with medication reconciliation.
American Society of Clinical Oncology Genitourinary Symposium and Integrative Healthcare Symposium [0.03%]
美国临床肿瘤学会泌尿生殖系统癌症研讨会及综合医疗研讨会
Walter Alexander
Walter Alexander
From ASCO, we report on metastatic castrate-resistant prostate cancer and locally advanced/metastatic renal cell carcinoma. From IHS, we report on complementary and alternative medicine use by patients and practitioners, the effects of biol...
Christopher Giuliano,Chandni R Patel,Pramodini B Kale-Pradhan
Christopher Giuliano
Purpose: To provide a guide to interpreting bacterial culture results. Methods: Studies were identified via a PubMed literature search ...
Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients [0.03%]
综合性慢性阻塞性肺病治疗互换项目对住院患者30天再入院率的影响
Maren A McGurran,Lisa M Richter,Nathan D Leedahl et al.
Maren A McGurran et al.
Purpose: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. The economic effect of COPD management is substantial, and the prevalence of the disease continues to rise wi...
Democratic Takeover of House Sparks Drug-Price Legislation Talks: But Strong Legislation Unlikely Given Patient and Industry Opposition [0.03%]
民主党重掌众议院 启动控药价立法谈判但患者和行业反对或使强立法无望
Stephen Barlas
Stephen Barlas
HHS has proposed regulations to attack high drug prices, a priority for the current administration. Both parties have spoken out against the drug companies but the change in control of the House is no guarantee of pricing legislation moving...
Pharmaceutical Approval Update [0.03%]
药品审批更新
Michele B Kaufman
Michele B Kaufman
Motegrity (prucalopride) for chronic idiopathic constipation; Aemcolo (rifamycin) for travelers' diarrhea; and Dextenza (dexamethasone ophthalmic insert) for ocular pain after ophthalmic surgery.
Drug and Device News [0.03%]
药物和器械新闻
Approvals, new indications and formulations, and safety issues.